tert-butyl 4-(6-((4-(benzo[d][1,3]dioxol-5-yl)-5-fluoropyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate

ID: ALA5207078

PubChem CID: 168295677

Max Phase: Preclinical

Molecular Formula: C25H27FN6O4

Molecular Weight: 494.53

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(C)OC(=O)N1CCN(c2ccc(Nc3ncc(F)c(-c4ccc5c(c4)OCO5)n3)nc2)CC1

Standard InChI:  InChI=1S/C25H27FN6O4/c1-25(2,3)36-24(33)32-10-8-31(9-11-32)17-5-7-21(27-13-17)29-23-28-14-18(26)22(30-23)16-4-6-19-20(12-16)35-15-34-19/h4-7,12-14H,8-11,15H2,1-3H3,(H,27,28,29,30)

Standard InChI Key:  MUXCEOPKLKSQPM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 36 40  0  0  0  0  0  0  0  0999 V2000
   -1.3472   -0.0016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6326    0.4106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0790   -0.0011    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0790   -0.8264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6308   -1.2382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3472   -0.8301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7937   -1.2390    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5084   -0.8264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5086   -0.0011    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2214    0.4094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9364   -0.0032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9380   -0.8243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2261   -1.2407    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6525   -1.2369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3674   -0.8244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0795   -1.2365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0795   -2.0619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3692   -2.4738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6525   -2.0656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8644   -2.3170    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3496   -1.6492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8644   -0.9815    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6510    0.4093    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0619    0.4109    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7765   -0.0016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4911    0.4109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4911    1.2360    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7765    1.6487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0619    1.2360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2057    1.6487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9204    1.2360    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2057    2.4738    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6350    1.6487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3496    1.2360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6350    2.4738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3496    2.0613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  6  5  2  0
  1  6  1  0
  4  7  1  0
  7  8  1  0
  9  8  2  0
 10  9  1  0
 11 10  2  0
 12 11  1  0
 13 12  2  0
  8 13  1  0
 12 14  1  0
 15 14  2  0
 16 15  1  0
 17 16  2  0
 18 17  1  0
 19 18  2  0
 14 19  1  0
 17 20  1  0
 21 20  1  0
 22 21  1  0
 16 22  1  0
 11 23  1  0
  1 24  1  0
 25 24  1  0
 26 25  1  0
 27 26  1  0
 28 27  1  0
 29 28  1  0
 24 29  1  0
 27 30  1  0
 30 31  1  0
 30 32  2  0
 31 33  1  0
 33 34  1  0
 33 35  1  0
 33 36  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5207078

    ---

Associated Targets(Human)

CCND1 Tchem CDK6/cyclin D1 (322 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 494.53Molecular Weight (Monoisotopic): 494.2078AlogP: 4.21#Rotatable Bonds: 4
Polar Surface Area: 101.94Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.81CX Basic pKa: 3.67CX LogP: 4.20CX LogD: 4.20
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.57Np Likeness Score: -1.34

References

1. Chen W, Ji M, Cheng H, Zheng M, Xia F, Min W, Yang H, Wang X, Wang L, Cao L, Yuan K, Yang P..  (2022)  Discovery, Optimization, and Evaluation of Selective CDK4/6 Inhibitors for the Treatment of Breast Cancer.,  65  (22.0): [PMID:36350721] [10.1021/acs.jmedchem.2c00947]

Source